If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Result of AGM

8 Apr 2020 12:38

RNS Number : 2439J
Maven Income and Growth VCT 3 PLC
08 April 2020
Β 

Β 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

Β 

At the Annual General Meeting of the Company held at Kintyre House, 205 West George Street, Glasgow, G2 2LW on Wednesday 8 April 2020 at 12.00 noon, all of the Resolutions put to the Meeting were passed.

Β 

At the record date for the Annual General Meeting, being 6 April 2020, the total number of voting rights in the Company stood at and the total shares in issue were 78,784,600. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 5,033,147Β shares and that the number of proxy votes lodged for each Resolution were as follows:

Β 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

4,862,956

142,560

5,940

21,691

5,033,147

2

To approve the Directors' Remuneration Report

4,624,721

142,560

156,417

109,449

5,033,147

3

To approve the Directors' Remuneration Policy

4,512,322

151,471

187,953

181,401

5,033,147

4

To approve a final dividend payment

4,868,734

142,560

6,102

15,751

5,033,147

5

To re-elect Atul Devani as a Director

4,767,122

159,082

65,173

41,770

5,033,147

6

To re-elect David Allan as a Director

4,802,092

159,082

29,464

42,509

5,033,147

7

To re-elect Bill Nixon as a Director

4,775,507

159,082

56,788

41,770

5,033,147

8

To re-elect Keith Pickering as a Director

4,740,079

210,198

47,312

35,558

5,033,147

9

To re-appoint Deloitte LLP as Auditor

4,357,481

183,676

464,034

27,956

5,033,147

10

To authorise the Directors to determine the remuneration of the Auditor

4,803,219

183,676

18,296

27,956

5,033,147

11

To authorise the Directors to allot new shares

4,471,413

192,587

305,062

64,085

5,033,147

12

To authorise disapplication of pre-emption rights

4,241,984

183,676

561,709

45,778

5,033,147

13

To authorise the Company to purchase its own shares

4,308,012

183,676

525,708

15,751

5,033,147

14

To allow a General Meeting to be called on not less than 14 days' notice

4,575,529

231,287

210,580

15,751

5,033,147

Β 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures, along with a summary of questions submitted to the AGM and the Board's responses to them, will be available to view at: www.mavencp.com/migvct3.

Β 

A copy of the Resolutions passed at the 2020 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

Β 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

8 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RAGKKFBNDBKDOQK
Date   Source Headline
2nd Jul 20264:55 pmRNSTransaction in Own Shares
26th Jun 202610:39 amRNSUnaudited Net Asset Value and Interim Dividend
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.